Inhibikase Therapeutics reported total assets of $163.59M and total liabilities of $10.26M for the quarter ended Jun 2026, up 84.1% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 44.85M | 40.75M | 36.61M | 32.21M | 5.78M | 7.19M | 3.96M | 1.91M | 14.86M | 9.17M | 2.35M | 3.09M | 0.91M | 56.49M | 73.44M | 77.74M | 38.27M | 139.22M | 49.57M | 31.21M | ||||||
| Short-term InvestmentsInvestments (Current) | 20.75M | 15.86M | 21.76M | 19.03M | 1.97M | 4.09M | 7.40M | 4.85M | 2.33M | 41.05M | 19.74M | 9.92M | 39.05M | 39.54M | 120.80M | 127.81M | ||||||||||
| Cash & Current Investments | 44.85M | 40.75M | 36.61M | 32.21M | 26.53M | 23.05M | 25.72M | 20.94M | 16.83M | 13.25M | 9.75M | 7.94M | 3.24M | 97.54M | 93.18M | 87.67M | 77.32M | 178.76M | 170.37M | 159.02M | ||||||
| Receivables - NetNet Receivables | 0.11M | 0.05M | 0.01M | 0.01M | 0.04M | 0.06M | 0.08M | |||||||||||||||||||
| Receivables - OtherOther Receivables | 0.22M | |||||||||||||||||||||||||
| Receivables | 0.11M | 0.05M | 0.01M | 0.01M | 0.04M | 0.06M | 0.08M | |||||||||||||||||||
| Prepaid Assets | 0.54M | 1.50M | 1.17M | 0.92M | 0.93M | 1.12M | 0.92M | 0.54M | 0.37M | 0.74M | 0.85M | 0.36M | 0.28M | 0.83M | 0.93M | 0.68M | 0.62M | 1.00M | 1.29M | 2.35M | ||||||
| Current Assets | 42.47M | 33.95M | 27.99M | 24.37M | 27.63M | 21.98M | 17.55M | 14.21M | 10.81M | 8.60M | 4.19M | 98.45M | 94.16M | 88.79M | 78.54M | 180.11M | 172.18M | 162.34M | ||||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.04M | 0.24M | 0.24M | 0.23M | 0.09M | 0.08M | 0.07M | 0.07M | 0.06M | 0.05M | 0.05M | 0.05M | 0.02M | |||||||||||||
| Other Non-Current Assets | 0.15M | 0.55M | 0.31M | 1.00M | 1.00M | 1.00M | 1.00M | |||||||||||||||||||
| Non-Current Assets | 0.04M | 0.59M | 0.57M | 0.53M | 0.36M | 0.33M | 0.30M | 0.26M | 0.22M | 0.19M | 0.15M | 0.12M | 0.06M | 1.06M | 1.10M | 1.16M | 1.24M | |||||||||
| Assets | 45.87M | 42.47M | 38.39M | 33.99M | 28.58M | 24.94M | 28.16M | 22.35M | 17.88M | 14.51M | 11.07M | 8.83M | 4.38M | 98.60M | 94.28M | 88.85M | 79.59M | 181.20M | 173.33M | 163.59M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 2.46M | 1.09M | 4.38M | 4.49M | 20.75M | 1.15M | 21.76M | 19.03M | 1.97M | 0.65M | 3.80M | 3.38M | 2.53M | 0.94M | 1.69M | 2.70M | 0.62M | 1.16M | 1.59M | 0.99M | ||||||
| Notes Payables | 0.25M | 0.25M | ||||||||||||||||||||||||
| Payables | 2.71M | 1.34M | 4.38M | 4.49M | 20.75M | 1.15M | 21.76M | 19.03M | 1.97M | 0.65M | 3.80M | 3.38M | 2.53M | 0.94M | 1.69M | 2.70M | 0.62M | 1.16M | 1.59M | 0.99M | ||||||
| Accumulated Expenses | 1.91M | 2.72M | 3.57M | 3.63M | 2.29M | 2.40M | 1.56M | 1.83M | 1.86M | 2.26M | 2.51M | 2.03M | 2.16M | 2.68M | 3.51M | 3.15M | 3.66M | 4.08M | 4.12M | 9.27M | ||||||
| Other Accumulated Expenses | 0.01M | 0.01M | 0.02M | 0.01M | 3.07M | 0.01M | 2.66M | 2.73M | 2.74M | 0.10M | 0.03M | 0.01M | 0.01M | 0.08M | 0.13M | 0.07M | 0.12M | 0.21M | 0.11M | 0.04M | ||||||
| Short term Debt | 0.14M | 0.15M | 0.15M | 0.15M | 0.15M | 0.15M | 0.15M | 0.15M | 0.15M | 0.11M | 0.07M | 0.04M | ||||||||||||||
| Current Deferred Revenue | 0.02M | 0.02M | ||||||||||||||||||||||||
| Total Current Liabilities | 2.71M | 4.05M | 3.21M | 3.70M | 2.66M | 2.73M | 2.74M | 3.44M | 4.23M | 3.70M | 4.91M | 3.73M | 8.55M | 8.80M | 6.70M | 8.30M | 5.71M | 10.26M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Capital Leases | 0.23M | 0.21M | 0.18M | 0.15M | 0.12M | 0.09M | 0.06M | |||||||||||||||||||
| Non-Current Debt | 0.25M | 0.25M | 0.38M | |||||||||||||||||||||||
| Minority Interest | 58.40M | 106.60M | ||||||||||||||||||||||||
| Other Non-Current Liabilities | 4.44M | 0.40M | 0.40M | |||||||||||||||||||||||
| Total Non-Current Liabilities | 4.29M | 4.12M | 5.31M | 9.86M | ||||||||||||||||||||||
| Total Liabilities | 2.71M | 4.05M | 4.38M | 4.49M | 3.45M | 3.90M | 2.84M | 2.88M | 2.86M | 3.53M | 4.29M | 3.73M | 4.91M | 3.73M | 8.55M | 8.80M | 6.70M | 8.30M | 5.71M | 10.26M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Total Debt | 0.50M | 0.50M | 0.14M | 0.15M | 0.15M | 0.15M | 0.15M | 0.53M | 0.15M | 0.15M | 0.15M | 0.11M | 0.07M | 0.04M | ||||||||||||
| Common Equity | 43.16M | 38.42M | 34.01M | 29.50M | 25.14M | 21.04M | 25.28M | 19.46M | 15.02M | 10.98M | 6.78M | 5.10M | -0.53M | 94.87M | 85.73M | 80.05M | 72.90M | 172.90M | 167.62M | 153.33M | ||||||
| Liabilities and Shareholders Equity | 45.87M | 42.47M | 38.39M | 33.99M | 28.58M | 24.94M | 28.16M | 22.35M | 17.88M | 14.51M | 11.07M | 8.83M | 4.38M | 98.60M | 94.28M | 88.85M | 79.59M | 181.20M | 173.33M | 163.59M | ||||||
| Retained Earnings | -24.78M | -29.82M | -34.46M | -39.10M | -43.59M | -47.87M | -52.35M | -58.13M | -62.72M | -66.90M | -71.55M | -76.51M | -82.29M | -94.42M | -108.10M | -118.01M | -129.95M | -142.68M | -159.10M | -178.70M |